These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 39066238)

  • 1. SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned.
    Lytton SD; Ghosh AK
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.
    To KK; Sridhar S; Chiu KH; Hung DL; Li X; Hung IF; Tam AR; Chung TW; Chan JF; Zhang AJ; Cheng VC; Yuen KY
    Emerg Microbes Infect; 2021 Dec; 10(1):507-535. PubMed ID: 33666147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach.
    Rahaman MM; Sarkar MMH; Rahman MS; Islam MR; Islam I; Saha O; Akter S; Banu TA; Jahan I; Habib MA; Goswami B; Bari L; Malek MA; Khan MS
    J Med Virol; 2022 Apr; 94(4):1670-1688. PubMed ID: 34939673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.
    Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
    Liu Q; Qin C; Liu M; Liu J
    Infect Dis Poverty; 2021 Nov; 10(1):132. PubMed ID: 34776011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of basic reproduction number (R
    Islam A; Sayeed MA; Rahman MK; Zamil S; Abedin J; Saha O; Hassan MM
    Infect Genet Evol; 2021 Aug; 92():104884. PubMed ID: 33930563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh.
    Al Nahid A; Ghosh A
    Infect Genet Evol; 2021 Nov; 95():105057. PubMed ID: 34481060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
    Totolian AA; Smirnov VS; Krasnov AA; Ramsay ES; Dedkov VG; Popova AY
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005859
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
    Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variants of SARS-CoV-2 and the challenges of vaccines.
    Han X; Ye Q
    J Med Virol; 2022 Apr; 94(4):1366-1372. PubMed ID: 34890492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitude and practices towards SARS-CoV-2 genetic mutations and emerging variants among the population in Bangladesh: a cross-sectional study.
    Ahmed I; Ether SA; Saha P; Jahan N; Rahman FI; Islam MR
    BMJ Open; 2023 Nov; 13(11):e073091. PubMed ID: 38030257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Hasan MM; Das R; Rasheduzzaman M; Hussain MH; Muzahid NH; Salauddin A; Rumi MH; Mahbubur Rashid SM; Siddiki AZ; Mannan A
    Virus Res; 2021 May; 297():198390. PubMed ID: 33737154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh.
    Cowley LA; Afrad MH; Rahman SIA; Mamun MMA; Chin T; Mahmud A; Rahman MZ; Billah MM; Khan MH; Sultana S; Khondaker T; Baker S; Banik N; Alam AN; Mannoor K; Banu S; Chowdhury A; Flora MS; Thomson NR; Buckee CO; Qadri F; Shirin T
    Nat Microbiol; 2021 Oct; 6(10):1271-1278. PubMed ID: 34497354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccinations: The unknowns, challenges, and hopes.
    Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh.
    Hossain MI; Sarker P; Raqib R; Rahman MZ; Hasan R; Svezia CK; Rahman M; Amin N
    Front Immunol; 2023; 14():1128330. PubMed ID: 36969162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.
    Zhang Y; Banga Ndzouboukou JL; Gan M; Lin X; Fan X
    Front Immunol; 2021; 12():771242. PubMed ID: 34880867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.